aTyr Pharma ATYR 深 沪
等待开盘 09-17 09:30:00 美东时间
1.08
+0.065
+6.40%
华盛通- 最 高1.20
- 今 开1.08
- 成交量 4634.51万股
- 最 低 1.06
- 昨 收 1.015
- 总市值 9612.48万
- 52周最高 7.2904
- 市盈率 静 --
- 换手率 52.07%
- 52周最低 1.00
- 委 比 15.94%
- 总股本 8900.44万
- 历史最高 396.06
- 量 比 1.25
- 振 幅 13.79%
- 历史最低 1.00
- 每 手 1
- 风险率 0.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
今天 10:15
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Check-Cap (NASDAQ:CHEK) shares rose 225.1% to $2.42 during Monday's re...
09-16 01:06
Court battle over Citgo parent auction kicks off in Delaware
A U.S. court in Delaware on Monday begins a pivotal hearing to decide the outcome of the auction of PDV Holding, parent of Venezuela-owned Citgo Petroleum, with creditors and bidders clashing over who...
09-15 21:22
aTyr Pharma shares are trading higher after Cantor Fitzgerald issued a Buy rating on the stock.
aTyr Pharma shares are trading higher after Cantor Fitzgerald issued a Buy rati...
09-13 01:27
Catalyst Watch: Apple event, Oracle earnings, and Klarna leads an IPO blitz
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Sunday - September...
09-06 03:00
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. granted three new employees nonstatutory stock options to purchase 62,400 shares of common stock at $5.71 per share under the 2022 Inducement Plan. The options vest over four years, with 25% vesting after one year and the remaining 75% in monthly installments over three years. aTyr is a clinical-stage biotech company leveraging tRNA synthetase biology to develop therapies for fibrosi...
09-05 20:00
美股大行评级 | 英伟达、Snowflake、万国数据、沃尔玛、Target等均获大行上调目标价
今日重点评级关注：杰富瑞：维持aTyr Pharma"买入"评级，目标价从9美元升至17美元；花旗：维持Ionis制药"买入"评级，目标价从65美元升至69美元
08-25 08:34
Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-23 03:41
Jefferies Maintains Buy on aTyr Pharma, Raises Price Target to $17
Jefferies analyst Roger Song maintains aTyr Pharma (NASDAQ:ATYR) with a Buy and raises the price target from $9 to $17.
08-23 01:40
